Venus Medtech (Hangzhou) Inc. (2500) Announces Patent Infringement Lawsuit Filing in Delaware

Bulletin Express

01/22

Venus Medtech (Hangzhou) Inc. (the Company) issued an announcement pursuant to Rule 13.10 of the Listing Rules. According to the announcement, Cardiovalve Ltd., a wholly owned subsidiary of the Company, and MTH IP, L.P., a joint venture of the Company, have filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Edwards Lifesciences Corp. and Edwards Lifesciences LLC.

The Company confirmed it is not aware of any information that must be announced to avoid a false market in its securities or of any inside information requiring disclosure under Rule 13.09(2) of the Listing Rules and Part XIVA of the Securities and Futures Ordinance. Shareholders and potential investors are advised to exercise caution when dealing in the Company’s shares.

The announcement is dated January 20, 2026.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1126243874"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1126243874\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1126243874?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-22 12:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126243874","market":"us","top_or_hot":-1,"title":"Venus Medtech (Hangzhou) Inc. (2500) Announces Patent Infringement Lawsuit Filing in Delaware","media":"Bulletin Express","content":"<p>Venus Medtech (Hangzhou) Inc. (the Company) issued an announcement pursuant to Rule 13.10 of the Listing Rules. According to the announcement, Cardiovalve Ltd., a wholly owned subsidiary of the Company, and MTH IP, L.P., a joint venture of the Company, have filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Edwards Lifesciences Corp. and Edwards Lifesciences LLC.</p>\n<p>The Company confirmed it is not aware of any information that must be announced to avoid a false market in its securities or of any inside information requiring disclosure under Rule 13.09(2) of the Listing Rules and Part XIVA of the Securities and Futures Ordinance. Shareholders and potential investors are advised to exercise caution when dealing in the Company’s shares.</p>\n<p>The announcement is dated January 20, 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Venus Medtech (Hangzhou) Inc. (2500) Announces Patent Infringement Lawsuit Filing in Delaware</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVenus Medtech (Hangzhou) Inc. (2500) Announces Patent Infringement Lawsuit Filing in Delaware\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-22 12:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Venus Medtech (Hangzhou) Inc. (the Company) issued an announcement pursuant to Rule 13.10 of the Listing Rules. According to the announcement, Cardiovalve Ltd., a wholly owned subsidiary of the Company, and MTH IP, L.P., a joint venture of the Company, have filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Edwards Lifesciences Corp. and Edwards Lifesciences LLC.</p>\n<p>The Company confirmed it is not aware of any information that must be announced to avoid a false market in its securities or of any inside information requiring disclosure under Rule 13.09(2) of the Listing Rules and Part XIVA of the Securities and Futures Ordinance. Shareholders and potential investors are advised to exercise caution when dealing in the Company’s shares.</p>\n<p>The announcement is dated January 20, 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02500","symbol_name":"启明医疗-B","start_time":0,"source_url":"","article_id":"1126243874","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126243874","pubTimestamp":1769054557,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Venus Medtech (Hangzhou) Inc. (the Company) issued an announcement pursuant to Rule 13.10 of the Listing Rules. According to the announcement, Cardiovalve Ltd., a wholly owned subsidiary of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02500":"启明医疗-B"},"translate_title":"维纳斯医疗科技（杭州）有限公司（2500）宣布在特拉华州提起专利侵权诉讼","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02500":1},"content_text":"Venus Medtech (Hangzhou) Inc. (the Company) issued an announcement pursuant to Rule 13.10 of the Listing Rules. According to the announcement, Cardiovalve Ltd., a wholly owned subsidiary of the Company, and MTH IP, L.P., a joint venture of the Company, have filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Edwards Lifesciences Corp. and Edwards Lifesciences LLC.\nThe Company confirmed it is not aware of any information that must be announced to avoid a false market in its securities or of any inside information requiring disclosure under Rule 13.09(2) of the Listing Rules and Part XIVA of the Securities and Futures Ordinance. Shareholders and potential investors are advised to exercise caution when dealing in the Company’s shares.\nThe announcement is dated January 20, 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}